These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34590746)

  • 1. Appetite-stimulating effects of once-daily omeprazole in cats with chronic kidney disease: Double-blind, placebo-controlled, randomized, crossover trial.
    Spencer A; Quimby JM; Price JM; MacLane S; Hillsman S; Secoura P; Steiner JM; Katherine Tolbert M
    J Vet Intern Med; 2021 Nov; 35(6):2705-2712. PubMed ID: 34590746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of compounded transdermal mirtazapine as an appetite stimulant in cats with chronic kidney disease.
    Quimby JM; Benson KK; Summers SC; Saffire A; Herndon AK; Bai S; Gustafson DL
    J Feline Med Surg; 2020 Apr; 22(4):376-383. PubMed ID: 31161850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic use of maropitant for the management of vomiting and inappetence in cats with chronic kidney disease: a blinded, placebo-controlled clinical trial.
    Quimby JM; Brock WT; Moses K; Bolotin D; Patricelli K
    J Feline Med Surg; 2015 Aug; 17(8):692-7. PubMed ID: 25336450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: a masked placebo-controlled crossover clinical trial.
    Quimby JM; Lunn KF
    Vet J; 2013 Sep; 197(3):651-5. PubMed ID: 23838205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Double-blind, Placebo-controlled, Multicenter, Prospective, Randomized Study of Beraprost Sodium Treatment for Cats with Chronic Kidney Disease.
    Takenaka M; Iio A; Sato R; Sakamoto T; Kurumatani H;
    J Vet Intern Med; 2018 Jan; 32(1):236-248. PubMed ID: 29131397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supplementation of vitamin E as an addition to a commercial renal diet does not prolong survival of cats with chronic kidney disease.
    Krofič Žel M; Tavčar Kalcher G; Vovk T; Žegura B; Lusa L; Tozon N; Nemec Svete A
    BMC Vet Res; 2024 Jul; 20(1):308. PubMed ID: 38987749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of intravenous adipose-derived allogeneic mesenchymal stem cells for the treatment of feline chronic kidney disease: a randomized, placebo-controlled clinical trial in eight cats.
    Quimby JM; Webb TL; Randall E; Marolf A; Valdes-Martinez A; Dow SW
    J Feline Med Surg; 2016 Feb; 18(2):165-71. PubMed ID: 25784460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug exposure and clinical effect of transdermal mirtazapine in healthy young cats: a pilot study.
    Benson KK; Zajic LB; Morgan PK; Brown SR; Hansen RJ; Lunghofer PJ; Wittenburg LA; Gustafson DL; Quimby JM
    J Feline Med Surg; 2017 Oct; 19(10):998-1006. PubMed ID: 27613493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats.
    Šutalo S; Ruetten M; Hartnack S; Reusch CE; Kook PH
    J Vet Intern Med; 2015; 29(3):840-6. PubMed ID: 25966746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the effect of gabapentin on blood pressure in cats with and without chronic kidney disease.
    Quimby JM; Jones SE; Saffire A; Brusach KK; Kurdziel K; George Z; Paschall RE; Aarnes TK
    J Feline Med Surg; 2024 May; 26(5):1098612X241240326. PubMed ID: 38770706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Chinese rhubarb, Rheum officinale, with and without benazepril on the progression of naturally occurring chronic kidney disease in cats.
    Hanzlicek AS; Roof CJ; Sanderson MW; Grauer GF
    J Vet Intern Med; 2014; 28(4):1221-8. PubMed ID: 24773179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Gastric pH and Serum Gastrin Concentrations in Cats with Chronic Kidney Disease.
    Tolbert MK; Olin S; MacLane S; Gould E; Steiner JM; Vaden S; Price J
    J Vet Intern Med; 2017 Sep; 31(5):1414-1419. PubMed ID: 28833548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effect of orally administered acid suppressants on intragastric pH in cats.
    Parkinson S; Tolbert K; Messenger K; Odunayo A; Brand M; Davidson G; Peters E; Reed A; Papich MG
    J Vet Intern Med; 2015 Jan; 29(1):104-12. PubMed ID: 25537303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of cetirizine hydrochloride on the pruritus of cats with atopic dermatitis: a randomized, double-blind, placebo-controlled, crossover study.
    Wildermuth K; Zabel S; Rosychuk RA
    Vet Dermatol; 2013 Dec; 24(6):576-81, e137-8. PubMed ID: 24112588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo-controlled, randomized study to evaluate the weight gain drug, mirtazapine transdermal ointment, in cats with unintended weight loss.
    Poole M; Quimby JM; Hu T; Labelle D; Buhles W
    J Vet Pharmacol Ther; 2019 Mar; 42(2):179-188. PubMed ID: 30506924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of low-dose meloxicam in cats with chronic kidney disease.
    KuKanich K; George C; Roush JK; Sharp S; Farace G; Yerramilli M; Peterson S; Grauer GF
    J Feline Med Surg; 2021 Feb; 23(2):138-148. PubMed ID: 32594827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Efficacy of Long-term Oral Treatment with Telmisartan and Benazepril in Cats with Chronic Kidney Disease.
    Sent U; Gössl R; Elliott J; Syme HM; Zimmering T
    J Vet Intern Med; 2015; 29(6):1479-87. PubMed ID: 26474314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of the effect of acid-suppressant therapy on clinicopathologic parameters of cats with chronic kidney disease.
    Gould E; Klos J; Price J; Harris T; Vaden S; Tolbert MK
    J Feline Med Surg; 2018 Jun; 20(6):520-527. PubMed ID: 28703633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and erythrocyte glutathione peroxidase activity, serum selenium concentration, and plasma total antioxidant capacity in cats with IRIS stages I-IV chronic kidney disease.
    Krofič Žel M; Tozon N; Nemec Svete A
    J Vet Intern Med; 2014; 28(1):130-6. PubMed ID: 24341729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing omeprazole with fluoxetine for treatment of patients with heartburn and normal endoscopy who failed once daily proton pump inhibitors: double-blind placebo-controlled trial.
    Ostovaneh MR; Saeidi B; Hajifathalian K; Farrokhi-Khajeh-Pasha Y; Fotouhi A; Mirbagheri SS; Emami H; Barzin G; Mirbagheri SA
    Neurogastroenterol Motil; 2014 May; 26(5):670-8. PubMed ID: 24533896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.